BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 27586511)

  • 1. Opioid-Induced Androgen Deficiency (OPIAD): Diagnosis, Management, and Literature Review.
    O'Rourke TK; Wosnitzer MS
    Curr Urol Rep; 2016 Oct; 17(10):76. PubMed ID: 27586511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid-induced androgen deficiency (OPIAD).
    Smith HS; Elliott JA
    Pain Physician; 2012 Jul; 15(3 Suppl):ES145-56. PubMed ID: 22786453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management Strategies in Opioid Abuse and Sexual Dysfunction: A Review of Opioid-Induced Androgen Deficiency.
    Hsieh A; DiGiorgio L; Fakunle M; Sadeghi-Nejad H
    Sex Med Rev; 2018 Oct; 6(4):618-623. PubMed ID: 30057139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid Related Endocrinopathy.
    Gudin JA; Laitman A; Nalamachu S
    Pain Med; 2015 Oct; 16 Suppl 1():S9-15. PubMed ID: 26461076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone deficiency in non-cancer opioid-treated patients.
    Coluzzi F; Billeci D; Maggi M; Corona G
    J Endocrinol Invest; 2018 Dec; 41(12):1377-1388. PubMed ID: 30343356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of salivary testosterone and male sexual dysfunction in opioid-associated androgen deficiency (OPIAD).
    Ajo R; Segura A; Mira L; Inda MD; Alfayate R; Sánchez-Barbie A; Margarit C; Peiró AM
    Aging Male; 2017 Mar; 20(1):1-8. PubMed ID: 27750480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The endocrine effects of long-term oral opioid therapy: a case report and review of the literature.
    Elliott JA; Horton E; Fibuch EE
    J Opioid Manag; 2011; 7(2):145-54. PubMed ID: 21561038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency.
    Daniell HW; Lentz R; Mazer NA
    J Pain; 2006 Mar; 7(3):200-10. PubMed ID: 16516826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain.
    Daniell HW
    J Pain; 2008 Jan; 9(1):28-36. PubMed ID: 17936076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid-induced hypogonadism: why and how to treat it.
    De Maddalena C; Bellini M; Berra M; Meriggiola MC; Aloisi AM
    Pain Physician; 2012 Jul; 15(3 Suppl):ES111-8. PubMed ID: 22786450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism.
    Tirabassi G; Delli Muti N; Corona G; Maggi M; Balercia G
    J Sex Med; 2014 May; 11(5):1302-8. PubMed ID: 24593124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioids and the Hypothalamic-Pituitary-Gonadal (HPG) Axis.
    Wehbeh L; Dobs AS
    J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32770254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone replacement therapy of opioid-induced male hypogonadism improved body composition but not pain perception: a double-blind, randomized, and placebo-controlled trial.
    Glintborg D; Vaegter HB; Christensen LL; Bendix E; Graven-Nielsen T; Andersen PG; Andersen M
    Eur J Endocrinol; 2020 Jun; 182(6):539-548. PubMed ID: 32213659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone Replacement Therapy and Opioid Tapering for Opioid-Induced Hypogonadism Among Patients with Chronic Noncancer Pain: A Systematic Review.
    AminiLari M; Manjoo P; Craigie S; Couban R; Wang L; Busse JW
    Pain Med; 2019 Feb; 20(2):301-313. PubMed ID: 29727002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidating risk factors for androgen deficiency associated with daily opioid use.
    Rubinstein A; Carpenter DM
    Am J Med; 2014 Dec; 127(12):1195-201. PubMed ID: 25063648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clomiphene citrate and enclomiphene for the treatment of hypogonadal androgen deficiency.
    Kaminetsky J; Hemani ML
    Expert Opin Investig Drugs; 2009 Dec; 18(12):1947-55. PubMed ID: 19938905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of testosterone treatment on bone mineral density in hypogonadal men receiving intrathecal opioids.
    Finch PM; Price LM; Pullan PT; Drummond PD
    Pain Pract; 2015 Apr; 15(4):308-13. PubMed ID: 24690205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doubts about treating hypogonadism due to long-term opioid use with testosterone therapy: a teachable moment.
    Murphy EN; Miranda R
    JAMA Intern Med; 2014 Dec; 174(12):1892-3. PubMed ID: 25317939
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy.
    Ide V; Vanderschueren D; Antonio L
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone health in hypogonadal men.
    Irwig MS
    Curr Opin Urol; 2014 Nov; 24(6):608-13. PubMed ID: 25144148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.